Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)

Neelapu, S. S., Chavez, J. C., Sehgal, A. R., Epperla, N., Ulrickson, M. L., Bachy, E., Munshi, P. N., Casulo, C., Maloney, D. G., de Vos, S., Reshef, R., Leslie, L. A., Oluwole, O. O., Yakoub-Agha, I., Khanal, R., Rosenblatt, J. D., Sherman, M., Dong, J., Giovanetti, A., … Jacobson, C. (2021). Long-Term Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL). Blood, 138(Supplement 1), 93–93. https://doi.org/10.1182/blood-2021-148473
Authors:
Sattva S. Neelapu
Julio C. Chávez
Alison R. Sehgal
Narendranath Epperla
Matthew L. Ulrickson
Emmanuel Bachy
Pashna N. Munshi
Carla Casulo
David G. Maloney
Sven de Vos
Ran Reshef
Lori A. Leslie
Olalekan O. Oluwole
Ibrahim Yakoub‐Agha
Rashmi Khanal
Joseph D. Rosenblatt
M. Sherman
Jinghui Dong
Alessandro Giovanetti
Yin Yang
Christine Lui
Zahid Bashir
A Scott Jung
Caron A. Jacobson
Affiliated Authors:
Ran Reshef
Subjects:
Publication Type:
Article
Unique ID:
10.1182/blood-2021-148473
Journal:
Publication Date:
Data Source:
OpenAlex

Record Created: